CVS Health raised its full-year 2026 profit forecast on Wednesday after first-quarter results topped Wall Street estimates, driven by improved medical cost controls at its Aetna insurance unit. For the full year, CVS now targets adjusted earnings per share between $7.30 and $7.50, compared with previous guidance of $7.00 to $7.20. Full-year revenue guidance was raised to at least $405 billion from at least $400 billion. Cash flow from operations guidance also increased to at least $9.5 billion from at lea ...